261 related articles for article (PubMed ID: 16998202)
1. Polyamine analogs with xylene rings induce antizyme frameshifting, reduce ODC activity, and deplete cellular polyamines.
Petros LM; Graminski GF; Robinson S; Burns MR; Kisiel N; Gesteland RF; Atkins JF; Kramer DL; Howard MT; Weeks RS
J Biochem; 2006 Nov; 140(5):657-66. PubMed ID: 16998202
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
[TBL] [Abstract][Full Text] [Related]
3. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
Ghoda L; Basu HS; Porter CW; Marton LJ; Coffino P
Mol Pharmacol; 1992 Aug; 42(2):302-6. PubMed ID: 1513327
[TBL] [Abstract][Full Text] [Related]
4. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
Nilsson J; Grahn B; Heby O
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
[TBL] [Abstract][Full Text] [Related]
5. Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs.
Mitchell JL; Thane TK; Sequeira JM; Marton LJ; Thokala R
Amino Acids; 2007 Aug; 33(2):291-7. PubMed ID: 17410332
[TBL] [Abstract][Full Text] [Related]
6. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
Keren-Paz A; Bercovich Z; Kahana C
Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
[TBL] [Abstract][Full Text] [Related]
7. Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis.
Faaland CA; Thomas TJ; Balabhadrapathruni S; Langer T; Mian S; Shirahata A; Gallo MA; Thomas T
Biochem Cell Biol; 2000; 78(4):415-26. PubMed ID: 11012080
[TBL] [Abstract][Full Text] [Related]
8. Polyamine sensing during antizyme mRNA programmed frameshifting.
Petros LM; Howard MT; Gesteland RF; Atkins JF
Biochem Biophys Res Commun; 2005 Dec; 338(3):1478-89. PubMed ID: 16269132
[TBL] [Abstract][Full Text] [Related]
9. Divergent regulation of the key enzymes of polyamine metabolism by chiral alpha-methylated polyamine analogues.
Hyvönen MT; Howard MT; Anderson CB; Grigorenko N; Khomutov AR; Vepsäläinen J; Alhonen L; Jänne J; Keinänen TA
Biochem J; 2009 Aug; 422(2):321-8. PubMed ID: 19522702
[TBL] [Abstract][Full Text] [Related]
10. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
[TBL] [Abstract][Full Text] [Related]
11. Polyamine-independent Expression of Caenorhabditis elegans Antizyme.
Stegehake D; Kurosinski MA; Schürmann S; Daniel J; Lüersen K; Liebau E
J Biol Chem; 2015 Jul; 290(29):18090-18101. PubMed ID: 26032421
[TBL] [Abstract][Full Text] [Related]
12. Polyamines regulate their synthesis by inducing expression and blocking degradation of ODC antizyme.
Palanimurugan R; Scheel H; Hofmann K; Dohmen RJ
EMBO J; 2004 Dec; 23(24):4857-67. PubMed ID: 15538383
[TBL] [Abstract][Full Text] [Related]
13. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.
Bettuzzi S; Davalli P; Astancolle S; Carani C; Madeo B; Tampieri A; Corti A
Cancer Res; 2000 Jan; 60(1):28-34. PubMed ID: 10646846
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor.
Kahana C
Essays Biochem; 2009 Nov; 46():47-61. PubMed ID: 20095969
[TBL] [Abstract][Full Text] [Related]
15. Properties of a polyamine transporter regulated by antizyme.
Sakata K; Kashiwagi K; Igarashi K
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):297-303. PubMed ID: 10727431
[TBL] [Abstract][Full Text] [Related]
16. Polyamine homoeostasis.
Persson L
Essays Biochem; 2009 Nov; 46():11-24. PubMed ID: 20095967
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.
Keren-Paz A; Bercovich Z; Porat Z; Erez O; Brener O; Kahana C
Oncogene; 2006 Aug; 25(37):5163-72. PubMed ID: 16568078
[TBL] [Abstract][Full Text] [Related]
18. Identification of regulatory region of antizyme necessary for the negative regulation of polyamine transport.
Sakata K; Fukuchi-Shimogori T; Kashiwagi K; Igarashi K
Biochem Biophys Res Commun; 1997 Sep; 238(2):415-9. PubMed ID: 9299523
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of testis specific ornithine decarboxylase antizyme (OAZ-t) gene: expression in haploid germ cells and polyamine-induced frameshifting.
Tosaka Y; Tanaka H; Yano Y; Masai K; Nozaki M; Yomogida K; Otani S; Nojima H; Nishimune Y
Genes Cells; 2000 Apr; 5(4):265-76. PubMed ID: 10792465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
